Target intelligence / Profile preview

Cell-Matrix Interface and Matrix-Bound Factors

Molecular classification
Other, Multiprotein complex, Cell adhesion complex, Extracellular vesicle (for matrix-bound nanovesicles)
01

Overview

The **cell–matrix interface** encompasses the collective molecular and structural elements at the boundary between a cell and the surrounding **extracellular matrix (ECM)**. It includes cell adhesion molecules (especially the integrin family), cytoskeletal scaffolding proteins, and a diverse range of matrix-bound factors such as growth factors, cytokines, and matrix-bound nanovesicles[1][6]. These complexes coordinate bidirectional communication via biochemical and mechanical signals, influencing processes like cell survival, proliferation, migration, and differentiation[1][3][5][9]. The ECM also acts as a reservoir or modulator for growth factors and signaling molecules (“matrix-bound factors”), which are sequestered or released under specific physiological and pathological conditions[8]. Matrix-bound nanovesicles, embedded in ECM structures, add another regulatory layer by transferring proteins, RNAs, and other bioactive molecules between cells and may serve as disease or tissue repair modulators[6][4]. This "interface" is not a single targetable molecule or receptor, but a dynamic, multipart signaling and structural system[1][5][9].

Other names
Cell–extracellular matrix interfaceECM–cell interfaceMatrix-bound nanovesiclesMatrix-bound factorsMatrix adhesions
02

Mechanism of action

Modulation of cell adhesion and migration Regulation of signaling via integrins and growth factors Control of tissue regeneration and repair via ECM-bound signaling molecules

03

Biological functions

Cell adhesionSignal transductionCell migrationCell survivalDifferentiationTissue remodelingCommunication of biochemical and mechanical signals
04

Disease associations

CancerWound healingFibrosisCardiovascular diseaseRegeneration and tissue repairInflammation
05

Safety considerations

Aberrant or excessive ECM remodeling and adhesion are linked to tumor invasion, metastasis, and fibrosis[1][5][9]Modulation of ECM binding can limit systemic toxicity of therapeutics, but misregulation may alter tissue homeostasis[8]

Beyond the preview

Go deeper on Cell-Matrix Interface and Matrix-Bound Factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-Matrix Interface and Matrix-Bound Factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call